Stay updated with breaking news from These Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dupixent (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old 68% of children
NY City, New York, United States, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Diamond in the Rough Click here for full length version of article. Allarity...
16.05.2022 - AV-101 is being developed to address cellular hyperproliferation and resistance to apoptosis in the pulmonary vasculature, which are key features of the pathophysiology of PAH PAH is an area of high unmet need, and currently approved therapies are ... Seite 1
Ad hoc announcement pursuant to Art. 53 LR Cash and cash equivalents of CHF 8.0 million (as of June 30, 2021)Net revenue CHF 4.5 million (H1-2020:...
Ad hoc announcement pursuant to Art. 53 LR Cash and cash equivalents of CHF 8.0 million (as of June 30, 2021)Net revenue CHF 4.5 million (H1-2020: CHF 7.8 million)Net result for period of CHF -20.5